Our system is currently under heavy load due to increased usage. We're actively working on upgrades to improve performance. Thank you for your patience.
2017
DOI: 10.4103/2277-9175.219412
|View full text |Cite
|
Sign up to set email alerts
|

Pseudomonas aeruginosa-producing Metallo-β-lactamases (VIM, IMP, SME, and AIM) in the Clinical Isolates of Intensive Care Units, a University Hospital in Isfahan, Iran

Abstract: Background:Pseudomonas aeruginosa is a severe challenge for antimicrobial therapy, due to the chromosomal mutations or exhibition of intrinsic resistance to various antimicrobial agents such as most β-lactams. We undertook this study to evaluate the existence of SME, IMP, AIM, and VIM metallo-β-lactamases (MBL) encoding genes among P. aeruginosa strains isolated from Intensive Care Unit (ICU) patients in Al-Zahra Hospital in Isfahan, Iran.Materials and Methods:In a retrospective cross-sectional study that was … Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1
1
1

Citation Types

0
4
1
2

Year Published

2018
2018
2024
2024

Publication Types

Select...
9

Relationship

0
9

Authors

Journals

citations
Cited by 13 publications
(7 citation statements)
references
References 22 publications
(33 reference statements)
0
4
1
2
Order By: Relevance
“…The enzyme included three types: SME-1, SME-2, and SME-3, identified in different parts of the United States (Queenan and Bush, 2007;Walther-Rasmussen and H‫ר‬iby, 2007). While these enzymes were not previously determined in our country, our results were contrasted with the results of local and global studies to investigate these enzymes in P. aeruginosa isolates (Al-Shara, 2013; Khorvash et al, 2017).…”
Section: Discussioncontrasting
confidence: 65%
“…The enzyme included three types: SME-1, SME-2, and SME-3, identified in different parts of the United States (Queenan and Bush, 2007;Walther-Rasmussen and H‫ר‬iby, 2007). While these enzymes were not previously determined in our country, our results were contrasted with the results of local and global studies to investigate these enzymes in P. aeruginosa isolates (Al-Shara, 2013; Khorvash et al, 2017).…”
Section: Discussioncontrasting
confidence: 65%
“…in clinical settings (Azizi et al, 2015; Zanganeh and Eftekhar, 2015; Shoja et al, 2016, 2017; Mohajeri et al, 2017; Sarikhani et al, 2017; Zafari et al, 2017; Rezaei et al, 2018; Shirmohammadlou et al, 2018). Other carbapenem resistance genes included OXA-24, OXA-58, IMP, VIM, KPC, GIM, SIM, and SPM (Peymani et al, 2011; Azimi et al, 2015; Bagheri Josheghani et al, 2015; Aghamiri et al, 2016; Maspi et al, 2016; Moghadam et al, 2016; Khorvash et al, 2017; Armin et al, 2018; Soltani et al, 2018). Isolated strains of carbapenem resistant A. baumannii are genetically diverse with the predominance of International clone I and II (Peymani et al, 2011; Savari et al, 2017; Mahdian et al, 2015; Sarhaddi et al, 2017).…”
Section: Distribution Of Multi-drug Resistant Organisms In Humansmentioning
confidence: 99%
“…Среди выделенных штаммов 100% были резистентны к цефалоспоринам 2 поколения (цефоперазон) и фосфомицинам, высокий уровень резистентности был выявлен к неустойчивым к β-лактамазе пенициллинам и β-лактамным пенициллинам, цефалоспоринам 4 поколения (93,9 ± 2,4%). Эффективным [5,6]. Частота встречаемости была следующей: у P. aeruginosa ген blaIMP определялся в 19% случаев, ген blaVIMв 45%.…”
Section: результаты и обсуждениеunclassified
“…Гены, кодирующие МБЛ, входят в состав плазмид, что способствует их быстрому внутри-и межвидовому распространению. Оно часто носит эпидемический характер, при этом доминируют определенные штаммы или ферменты в масштабах как отдельных центров, так и обширных географических зон [4][5][6]. Популяции микроорганизмов, складывающиеся в условиях стационара, всегда состоят из штаммов с высокой вирулентностью и антибиотикоустойчивостью.…”
Section: Introductionunclassified